Final Category I CPT Codes and Reimbursement Rates Introduced
Olympus Corporation, a leading global medical technology firm, is excited to report that the Centers for Medicare and Medicaid Services (CMS) have finalized the Category I Current Procedural Terminology (CPT) codes and reimbursement rates for the iTind procedure. This announcement marks a significant milestone in enhancing healthcare accessibility for men dealing with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH).
What is the iTind Procedure?
The iTind procedure offers a minimally invasive solution for men suffering from LUTS. By utilizing a temporarily implanted nitinol device, the procedure reshapes the prostatic urethra, requiring neither cutting nor burning of prostate tissue. This is typically performed in an outpatient setting, allowing patients to return home the same day. The device remains in place for five to seven days, after which patients experience significant symptom relief with long-lasting results.
New CPT Codes and Their Impact
With the establishment of two new CPT codes, 53865 for insertion and 53866 for removal of the iTind device, this procedure is now more accessible across various healthcare settings. Matt Moore, Vice President of Health Economics and Market Access at Olympus Corporation, emphasized the importance of these codes for those suffering from BPH. He stated, "The new CPT codes support greater access to a proven minimally invasive treatment option and help streamline the billing process, potentially reducing the administrative burdens faced by healthcare providers."
Patient Experience and Benefits
Clinical studies have shown that the iTind procedure does not adversely affect sexual or urinary function, making it a preferable option for many men. Glen Branconier, Global Vice President of Olympus’s Therapeutic Solutions Division, noted that with the introduction of these CPT codes, more patients will be able to receive the treatment they need, leading to an improved quality of life.
Support for Patients and Healthcare Providers
The Olympus UNITE program offers additional resources to streamline the insurance process for eligible patients. This program includes support for pre-authorization and appeals, as well as a helpline to address coding and payment questions. Healthcare providers can also access assistance from Olympus Field Reimbursement Managers, who are equipped with valuable insights regarding reimbursement and can guide them through the overall process.
About Olympus
Olympus is dedicated to the purpose of making people's lives healthier and more fulfilling. By collaborating with healthcare professionals, the company offers solutions for early detection, diagnosis, and minimally invasive treatments aimed at improving patient outcomes. With over a century of experience, Olympus continues to enhance its product offerings to ensure optimal results for patients globally.
Frequently Asked Questions
What is the purpose of the iTind procedure?
The iTind procedure is designed to provide minimally invasive treatment for men experiencing lower urinary tract symptoms due to benign prostatic hyperplasia.
What are the new CPT codes for the iTind procedure?
The CPT codes introduced for the iTind procedure are 53865 for insertion and 53866 for removal of the device.
How does the iTind device function?
The device reshapes the prostatic urethra without cutting or burning tissue, and it is temporarily placed for five to seven days to provide relief from urinary symptoms.
Are there any side effects associated with the iTind procedure?
While iTind is generally safe, possible side effects include pelvic discomfort and urinary issues, which usually resolve after the device is removed.
How can patients get help with insurance coverage for the iTind procedure?
Patients can access support through the Olympus UNITE program, which assists with insurance navigation, including pre-authorization and patient appeals.
